C84.70
BillableAnaplastic large cell lymphoma, ALK-negative, unspecified site
HCC Category Mapping
What This Code Means
A type of aggressive lymphoma (cancer of immune cells) that lacks a specific genetic marker (ALK-negative) and the exact location of the cancer is not specified.
Coding Tips
- •This is an unspecified site code; attempt to obtain more specific anatomical location from the pathology report or clinical documentation
- •ALK-negative status should be confirmed through immunohistochemistry or molecular testing documented in the medical record
Clinical Significance
Anaplastic large cell lymphoma, ALK-negative, unspecified site is an aggressive T-cell lymphoma lacking the ALK fusion protein. ALK-negative ALCL has a significantly worse prognosis than ALK-positive disease, with 5-year survival rates of approximately 40-50%. This distinction is critical because it affects treatment decisions and clinical trial eligibility. The unspecified site indicates the anatomical location was not documented.
Documentation Requirements
- ✓Pathology confirming ALCL with hallmark cells and CD30 positivity
- ✓ALK-negative status confirmed by immunohistochemistry or molecular testing
- ✓T-cell immunophenotype confirmed
- ✓Clinical staging documentation
- ✓Provider should be queried for specific site of involvement to enable more specific coding